Blueprint for an Innovation Economy in Florida Research as Economic Foundation | Page 25
BIT A
Post Material Revenue - R&D Mostly AxoGen Funded. Outcome: Product Line Scaling
Microsurgery, Peer Review of
Clinical Research at 12 Sites
Oral and Maxillofacial
Surgery, Shanti R, Zaccardi V
Exp Neurology, Neurbauer
D, Muir D, et.al.
Krekoski
.al.
J of Neurodegeneration &
Regeneration, Graham JB, Muir D,
J,
Exp Neurology, Neubaurer D,
Muir D, et.al.
Shirley Pincus
Surgery
Annals of Plastic Surgery,
Duic I, Rose F, et.al.
Exp Neurology, Muir D
Scale Product Line, Face &
Breast Reconstruction,
Podiatry, Prostatectomy, Pain
Journal of Hand Surgery,
Cho M, Rinker B, et.al.
Hand, Karabekmez F, Microsurgery, Brooks D,
Weber R, et.al.
Duymaz A, et.al.
Exp Neurology,
Graham JB, Muir D,
Gen, Muir D, Grant
K, 7 Grants, 10 YR*
Debt Financing, $2.62M
DOD, Muir D, Venture, $18M
Grant $1M, 3 YR Equity Raise
Debt Financing, $3M
Post IPO, $17.5M
Equity Raise
Post IPO, $13M
Equity Raise
Debt Financing, $3.7M
Series C, $12.1M
Equity Raise
Investors,
Raise
ue - R&D Mostly AxoGen Funded. Outcome: Efficacy & Surgical Techniques
FY Fin, Rev $4.85M,
GP $2.42M
FY Fin, Rev $10.9M, FY Fin, Rev $27.33M,
GP $8.5M, GM 78%
GM 82.3%
FY Fin, Rev $7.69M,
GP $5.73M GM 75%
*LECTEC
Merger/IPO, Initial
Public Offering
FY Fin, Rev $16.8M,
GP $13.4, GM 79.5%
2nd QTR To Date Fin,
Rev $18.5M, GM 84%
23